SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001193125-15-140090
Filing Date
2015-04-21
Accepted
2015-04-21 16:07:10
Documents
3
Period of Report
2015-06-01
Effectiveness Date
2015-04-21

Document Format Files

Seq Description Document Type Size
1 DEFINITIVE PROXY STATEMENT d855023ddef14a.htm DEF 14A 252554
2 GRAPHIC g855023pc_pg1.jpg GRAPHIC 90349
3 GRAPHIC g855023pc_pg2.jpg GRAPHIC 193281
  Complete submission text file 0001193125-15-140090.txt   644863
Mailing Address 7999 GATEWAY BLVD SUITE 130 NEWARK CA 94560
Business Address 7999 GATEWAY BLVD SUITE 130 NEWARK CA 94560 510-293-8800
CymaBay Therapeutics, Inc. (Filer) CIK: 0001042074 (see all company filings)

IRS No.: 943103561 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-36500 | Film No.: 15783295
SIC: 2834 Pharmaceutical Preparations